tetraspan 100 mg/ml šķīdums infūzijām
b.braun melsungen ag, germany - hydroxyethylamylum, natrii chloridum, kalii chloridum, kalcija chloridum dihydricum, magnija chloridum hexahydricum, natrii acetas trihydricus, skābes l-malicum - Šķīdums infūzijām - 100 mg/ml
ciqorin 100 mg mīkstās kapsulas
teva pharma b.v., netherlands - ciklosporīns - mīkstās kapsulas - 100 mg
medopexol 0,7 mg tabletes
medochemie ltd., cyprus - pramipeksols - tablete - 0,7 mg
medopexol 0,18 mg tabletes
medochemie ltd., cyprus - pramipeksols - tablete - 0,18 mg
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiski līdzekļi - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
verkazia
santen oy - ciclosporin - conjunctivitis; keratitis - oftalmoloģiskie līdzekļi - Ārstēšana smagas pavasara keratoconjuntivitis (vkc) , bērniem no 4 gadu vecuma un pusaudžiem.
acetylcysteine olainfarm 200 mg pulveris iekšķīgi lietojama šķīduma pagatavošanai
olainfarm, as, latvia - acetilcisteīns - pulveris iekšķīgi lietojama šķīduma pagatavošanai - 200 mg
ultarcorlene 5 mg/g acu ziede
agepha pharma s.r.o., slovakia - prednisoloni pivalas - acu ziede - 5 mg/g
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfoma, mantle-cell - antineoplastiski līdzekļi - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
wintrozen 600 mg putojošās tabletes
zentiva, k.s., czech republic - acetilcisteīns - putojošā tablete - 600 mg